South Australian PrEPX study for those at risk for HIV infection
South Australians at a high risk of acquiring HIV will have the opportunity to enrol in a local Pre-Exposure Prophylaxis (PrEP*) research study which will be delivered through a partnership between Victoria’s Alfred Health, the South Australian Health and Medical Research Institute (SAHMRI) and SA Health. SHINE SA is involved at our 57 Hyde Street site.
500 people will be enrolled in the PrEPX-SA study which commenced in May. People interested in participating can register online. When a place becomes available, people who have registered are sent an email with information about how to make an appointment and other information about the study.
Communities most likely to benefit from PrEP include gay men, men who have sex with men (MSM), Aboriginal and Torres Strait Islander people, people from culturally and linguistically diverse backgrounds and partners of HIV-positive people.
Full details of the PrEPX-SA study can be found at: www.alfredhealth.org.au/prepxsa
*PrEP is an antiretroviral medication taken daily by people at the highest risk of HIV to prevent them from acquiring HIV. PrEP has been shown internationally and nationally to reduce the number of new cases. There will be a small co-payment for medication prescribed during the study.